Results 211 to 220 of about 9,118,901 (248)
Some of the next articles are maybe not open access.
Graft-versus-host disease and immunosuppression
Immunologic Research, 2008In the last four decades, allogeneic hematopoietic stem cell transplant (HSCT) has been established as a curative therapy for many otherwise fatal diseases. Since 1968, from the time of the first successful allogeneic bone marrow transplant in a child with severe combined immune deficiency disease [1], tremendous progress has been made in this field of
openaire +2 more sources
Enterococcus in Graft-versus-Host Disease
New England Journal of Medicine, 2020Susceptibility to Graft-versus-Host-Disease A major cause of poor outcome after allogeneic hematopoietic-cell transplantation is graft-versus-host disease.
openaire +2 more sources
Predicting graft-versus-host disease
Current Opinion in Immunology, 1995Graft-versus-host disease (GVHD) is a serious complication that occurs after allogeneic bone marrow transplantation and contributes to transplant-related morbidity and mortality. Recent advances in the measurement of recipient-specific alloreactivity before marrow grafting have led to the development of in vitro assays that sufficiently predict the ...
openaire +2 more sources
Graft-Versus-Host Disease: Implications
1993The intent of the preparative regimen for bone marrow transplantation (BMT) is the destruction of the host tumor cell and the complete ablation of the host lymphohematopoietic system (Thomas 1983). Most aggressive conditioning regimens are applied, usually combining chemo- and radiotherapy, the latter in the form of total body irradiation.
openaire +2 more sources
Graft‐versus‐host disease of the tongue
Otolaryngology–Head and Neck Surgery, 2009Jeffrey D, Suh +2 more
openaire +2 more sources
Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-Versus-Host Disease
New England Journal of Medicine, 2021Nicola Polverelli +2 more
exaly

